Mengyao Liu

3PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 23, 2025
First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial.

Jun-Kai Zhao, Zeng-Jun Liu, Rui Wang

|Aug 28, 2025
Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Heng Fu, Zengjun Liu, Mengyao Liu

|May 24, 2024
Two cases of inflammatory myofibroblastic tumor treated with targeted drugs: A case report.

Mengyao Liu, Dongyuan Zhu

Pageof 1

Frequent Collaborators

2 joint publications

Zengjun Liu

2 joint publications

Heng Fu

2 joint publications

Jing Xu

2 joint publications

Xin Xu